Cabergoline

Form: Tablets

Strength: 0.25 mg, 0.5 mg

Reference Brands: Dostinex®, Cabaser®

Category: Antipsychotropic Drugs

Cabergoline is a potent dopamine agonist used to treat hyperprolactinemia and manage symptoms in Parkinson’s disease. Available primarily as 0.25 mg and 0.5 mg oral tablets, it is marketed under brands like Dostinex® and Cabaser® in the US and EU. Cabergoline works by reducing prolactin levels through D2 receptor stimulation. Pharma B2B buyers can access Cabergoline from GMP-certified manufacturers, ensuring reliable quality, regulatory approvals (US FDA, EU GMP), and scalable bulk supply. Ideal for hospital tenders, specialty distributors, and endocrinology-focused pharmaceutical partners looking for a trusted Cabergoline source in regulated and semi-regulated markets.